
Ra Medical Systems RMED
Country |
|
IPO year |
2018 |
Industry |
Medical devices |
Stock Exchange |
NYSE AMERICAN |
Shares |
1.08 M |
Market Cap[1] |
$ 610 K |
EBITDA (LTM) |
$ -19 M |
P/E (LTM) |
- |
P/S (LTM) |
0.744884 |
EPS (LTM) |
-15.9 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
NuVasive
NUVA
|
- | - | $ 2.07 B | Nasdaq Global Select Market,SPB | ||
|
Varex Imaging Corporation
VREX
|
$ 18.45 | -0.35 % | $ 764 M | Nasdaq Global Select Market,SPB | ||
|
Vivos Therapeutics
VVOS
|
$ 0.1 | -8.63 % | $ 1.03 M | Nasdaq Global Select Market | ||
|
Beyond Air
XAIR
|
$ 2.18 | -6.84 % | $ 18.1 B | Nasdaq Global Select Market | ||
|
Zimmer Biomet Holdings
ZBH
|
$ 106.42 | -3.4 % | $ 21.1 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
ViewRay
VRAY
|
- | 1.54 % | $ 468 M | Nasdaq Global Select Market | ||
|
Medigus Ltd.
MDGS
|
- | 10.28 % | $ 55.5 M | Nasdaq Global Select Market | ||
|
Medtronic PLC
MDT
|
$ 104.91 | -0.11 % | $ 134 B | NYSE,SPB | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Vapotherm
VAPO
|
- | 6.72 % | $ 34 M | NYSE | ||
|
Nevro Corp.
NVRO
|
- | - | $ 217 M | NYSE,SPB | ||
|
Venus Concept
VERO
|
- | - | $ 726 K | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Sientra
SIEN
|
- | -16.59 % | $ 10.3 M | Nasdaq Global Select Market | ||
|
Silk Road Medical, Inc
SILK
|
- | - | $ 1.07 B | Nasdaq Global Select Market,SPB | ||
|
Surgalign Holdings
SRGA
|
- | -32.98 % | $ 1.68 M | Nasdaq Global Select Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
ShockWave Medical
SWAV
|
- | - | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
Inari Medical
NARI
|
- | - | $ 4.23 B | Nasdaq Global Select Market,SPB | ||
|
Zynex
ZYXI
|
- | - | $ 21.1 M | Nasdaq Capital Market,SPB | ||
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Titan Medical
TMDI
|
- | -26.32 % | $ 19.6 M | Nasdaq Global Select Market | ||
|
Natus Medical Incorporated
NTUS
|
- | 1.94 % | $ 1.05 B | Nasdaq Global Select Market,SPB | ||
|
Nemaura Medical
NMRD
|
- | -17.8 % | $ 2.74 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 6.06 | -10.55 % | $ 1.5 B | NYSE | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Cognyte Software Ltd.
CGNT
|
$ 8.08 | -8.6 % | $ 589 M | Nasdaq Global Select Market,SPB | ||
|
Alphatec Holdings
ATEC
|
$ 7.79 | -5.98 % | $ 1.17 B | Nasdaq Global Select Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 368.89 | -2.92 % | $ 10.1 B | NYSE,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 44.36 | -3.14 % | $ 65.7 B | NYSE,SPB | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Aethlon Medical
AEMD
|
$ 5.4 | -6.09 % | $ 3.64 M | Nasdaq Capital Market | ||
|
Apyx Medical Corporation
APYX
|
$ 3.06 | 18.15 % | $ 126 M | Nasdaq Global Select Market | ||
|
Establishment Labs Holdings
ESTA
|
$ 64.29 | -3.96 % | $ 1.9 B | Nasdaq Capital Market | ||
|
Delcath Systems
DCTH
|
$ 14.5 | -2.16 % | $ 519 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 26.83 | -5.53 % | $ 222 M | NYSE American | ||
|
Inogen
INGN
|
$ 6.78 | -6.09 % | $ 180 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 81.19 | -6.74 % | $ 11 B | NYSE,SPB | ||
|
IRadimed Corporation
IRMD
|
$ 85.34 | -3.66 % | $ 1.09 B | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 8.7 | -14.37 % | $ 246 M | Nasdaq Capital Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.12 | -18.04 % | $ 14.7 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 48.48 | -5.59 % | $ 2.23 B | Nasdaq Capital Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.